AwardedSpainGoodsFramework agreement€110,115,092
La contratación, mediante Acuerdo Marco con varios empresarios, del suministro sucesivo de los medicamentos de inmunoterapia oncológica para los centros hospitalarios del Servicio Gallego de Salud
- Published
- Published 25 June 2026
Overview
The Servicio Gallego de Salud has awarded a framework agreement for the successive supply of oncology immunotherapy medications to hospital centers in Galicia. The contract was awarded on 8 May 2026 to eight pharmaceutical suppliers including AstraZeneca, Bristol-Myers Squibb, Roche, and others, for a total value of approximately 50 million EUR.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €110,115,092
- Procedure
- Direct
- Contract type
- Framework agreement
- Published
- 25 June 2026
Antineoplastic agents
Award outcome
- Awarded value
- €50,052,315
- Award date
- 8 May 2026
- Contract period
- 16 June 2026 → 16 June 2027
- ASTRAZÉNECA FARMACÉUTICA SPAIN, S.A.
- BEONE MEDICINES ESP, S.L.U
- BRISTOL-MYERS SQUIBB, S.A.U.
- GLAXOSMITHKLINE, S.A.
- MERCK SHARP & DOHME DE ESPAÑA, S.A.
- MERCK, S.L.U.
- REGENERON SPAIN S.L.U.
- ROCHE FARMA S.A.U
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
25 June 2026
Contracting authority
Servicio Gallego de Salud
Procuring entitySantiago de Compostela, Spain
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.